SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-130026
Filing Date
2021-10-26
Accepted
2021-10-26 17:01:35
Documents
1
Period of Report
2021-10-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2130646-24_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2130646-24_4seq1.xml 4 18535
  Complete submission text file 0001104659-21-130026.txt   20666
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Fund XI, L.P. (Reporting) CIK: 0001708269 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 211349389

Mailing Address 400 TECHNOLOGY SQUARE, 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE, 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Opportunity Fund I, L.P. (Reporting) CIK: 0001759241 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 211349388

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations